Skip to main content

Peer Review reports

From: The efficacy and safety of intravitreal injection of Ranibizumab as pre-treatment for vitrectomy in proliferative diabetic retinopathy with vitreous hemorrhage

Original Submission
12 May 2021 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
14 Jun 2021 Reviewed Reviewer Report - Hemant Trehan
15 Aug 2021 Reviewed Reviewer Report
12 Sep 2021 Author responded Author comments - Chun Ding
Resubmission - Version 3
12 Sep 2021 Submitted Manuscript version 3
8 Oct 2021 Reviewed Reviewer Report - Mohamed Elashry
19 Oct 2021 Reviewed Reviewer Report
30 Oct 2021 Reviewed Reviewer Report
7 Nov 2021 Author responded Author comments - Chun Ding
Resubmission - Version 4
7 Nov 2021 Submitted Manuscript version 4
14 Nov 2021 Reviewed Reviewer Report
6 Jan 2022 Reviewed Reviewer Report
19 Jan 2022 Author responded Author comments - Chun Ding
Resubmission - Version 5
19 Jan 2022 Submitted Manuscript version 5
Publishing
2 Feb 2022 Editorially accepted
10 Feb 2022 Article published 10.1186/s12886-022-02303-3

You can find further information about peer review here.

Back to article page